The Cost-Effectiveness of Palliative Care: Insights from the PAL-HF Trial.

ABSTRACT:

Background

In a randomized control trial, Palliative Care in Heart Failure (PAL-HF) improved heart failure-related quality of life, though cost-effectiveness remains unknown. The aim of this study was to evaluate the cost-effectiveness of the PAL-HF trial, which provided outpatient palliative care to patients with advanced heart failure.

Methods and results

Outcomes for usual care and PAL-HF strategies were compared using a Markov cohort model over 36 months from a payer perspective. The model parameters were informed by PAL-HF trial data and supplemented with meta-analyses and Medicare administrative data. Outcomes included hospitalization, place of death, Medicare expenditures, quality-adjusted life years (QALYs), and incremental cost-effectiveness ratios. Simulated mortal

SUBMITTER: Kaufman BG 

PROVIDER: S-EPMC8180496 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature